Selexipag As Treatment Option For Pulmonary Arterial Hypertension
Besides being a serious condition that causes shortness of breath, pulmonary hypertension is also extremely dangerous since it has very few treatment options available, and no known cure. After the first symptoms start to show up, and you get you’re accurate diagnosis, you will want to treat this devastating disease that affects your whole life.
Fortunately, science and research is constantly evolving, leading to new discoveries that can mean new treatment options for PH. In this video, shared by dailyRx, is discussed the use of selexipag as treatment option for pulmonary arterial hypertension. A study was published showing the drug’s potential for treating PAH and stated that selexipag successfully cut the rates of hospitalization and worsening symptoms among PAH patients by 40 percent compared to placebo.
Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.